EMR Combined with CRB-65 Superior to CURB-65 in Predicting Mortality in Patients with Community-Acquired Pneumonia

Yi Sun,Hong Wang,Minghao Gu,Xingyu Zhang,Xuedong Liu,Xiudi Han

DOI: https://doi.org/10.2147/idr.s443045

2024-02-13

Infection and Drug Resistance

Abstract:Yi Sun, 1, 2 Hong Wang, 3 Minghao Gu, 4 Xingyu Zhang, 5 Xiudi Han, 1 , Xuedong Liu, 1 1 Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital Group, Qingdao, Shandong Province, 266000, People's Republic of China; 2 School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong Province, 261000, People's Republic of China; 3 Hospital-Acquired Infection Control Department, Qingdao Municipal Hospital Group, Qingdao, Shandong Province, 266000, People's Republic of China; 4 School of Medicine, Qingdao University, Qingdao, Shandong Province, 266000, People's Republic of China; 5 Human Resources Department, Qingdao Municipal Hospital Group, Qingdao, Shandong Province, 266000, People's Republic of China Correspondence: Xuedong Liu; Xiudi Han, Email ; Background: Data about eosinophil-to-lymphocyte ratio (ELR) and eosinophil-to-monocyte ratio (EMR) in patients with community-acquired pneumonia (CAP) are rare. We aimed to evaluate the role of EMR and ELR in predicting disease severity and mortality in patients with CAP. Methods: A total of 454 patients (76 with severe CAP (SCAP), 378 with non-SCAP) were enrolled from November 18, 2020, and November 21, 2021. Laboratory examination on day 1 after admission was measured. The ELR and EMR values were calculated for patients. Propensity score matching (PSM) was performed to balance potential confounding factors. Binary logistic regression model was fitted to identify the potential risk factors for disease severity and Cox proportional hazards regression model analysis for mortality in CAP. Receiver operating characteristic (ROC) analysis was performed to distinguish disease severity and mortality. Results: EMR and ELR at admission were significantly lower in SCAP patients than in non-SCAP patients ( P < 0.001). EMR < 0.018 ([OR] = 12.104, 95% CI: 4.970– 29.479), neutrophil (NEU) ([OR]=1.098, 95% CI:1.005– 1.199), and age ([OR]=1.091, 95% CI:1.054– 1.130) were independent risk factors for disease severity of CAP. EMR < 0.032 ([HR] = 5.816, 95% CI: 1.704– 9.848) was an independent predictor of in-hospital mortality. Combining EMR or ELR with CRB-65 improved the overall accuracy of disease severity prediction (AUC from 0.894 to 0.937), the same as CURB-65. The area under the curve of EMR (AUC=0.704; 95% CI: 0.582– 0.827) to predict in-hospital mortality was higher than that of CURB-65 (AUC=0.619; 95% CI: 0.484– 0.754). Otherwise, EMR combined with CRB-65 (AUC=0.721; 95% CI: 0.592– 0.851) had significantly higher diagnostic accuracy for in-hospital mortality than that of CURB-65 alone. Conclusion: EMR combined with CRB-65 was superior to CURB-65 in predicting mortality in patients with CAP. This new combination was simpler and easier to obtain for physicians in clinics or admission, and it was more convenient for early recognition of patients with poor prognoses. Keywords: community-acquired pneumonia, EMR, ELR, CURB-65, CRB-65, severity of disease, mortality Community-acquired pneumonia (CAP) is the leading cause of death among all infectious diseases and an important health problem, with a significant impact on healthcare systems worldwide. 1–3 In the United States of America (USA), CAP causes around 102,000 deaths per year, with mortality rates of 13%, 23.4%, and 30.6% at 1, 6, and 12 months, respectively. 4 Accurate assessment of CAP severity and prognosis is critical for diagnosis and treatment. The CURB-65 score—Confusion, Urea>7 mmol/L, Respiratory Rate≥30 breaths/min, Blood Pressure<90 mmHg (systolic) or ≤60 mmHg (diastolic), and Age≥65 years and CRB-65 score (a simplified version of CURB-65 without the blood urea) are widely used clinical scoring systems to predict the disease severity of CAP. CURB-65 and CRB-65 are applied owing to the advantages of being concise and easy-to-use. 5,6 However, neither CURB-65 nor CRB-65 could effectively evaluate the outcome of older patients with CAP because of the improper weighting of age variables. 7 At the same time, the vast majority of decisions concerning treatment location are made outpatient service without ready access to the results of blood urea nitrogen (BUN) (the "U" in CURB). Therefore, a better prediction index is the need of the hour for rapid, early clinical assessment. Eosinophils represent 1–4% of circulating leukocytes and have a pivotal role in the propagation of allergic conditions and immune and inflammatory networks. 8 Serum eosinophils were found to be a predictor of mortality in a prospective study. 9 However, a single indicator of inflammation is not a good predictor. In recent -Abstract Truncated-

pharmacology & pharmacy,infectious diseases